Approved Risk Evaluation and Mitigation Strategies (REMS)

REMS@FDA

Contact Us | REMS Resources | Gov Delivery Get REMS Email Alerts | Reports & Data Files

Dsuvia (sufentanil)
NDA #209128
REMS last update: 11/02/2018



What is the purpose of the REMS?

The goal of the DSUVIA REMS is to mitigate the risk of respiratory depression resulting from accidental exposure by ensuring that DSUVIA is dispensed only to patients in certified medically supervised healthcare settings.

What do participants need to know?

Below is a general overview of the REMS for all REMS participants (e.g., patients, pharmacies, and healthcare providers). See the application holder(s) REMS Website or the approved REMS materials for more information.

View application holder(s) REMS Website See Disclaimer page regarding links to external sites

Healthcare settings that dispense Dsuvia must:

To become certified to dispense
  • Be able to manage acute opioid overdose, including respiratory depression.
  • Designate an authorized representative to carry out the certification process and oversee implementation and compliance with the REMS Program on behalf of the healthcare setting.
  • Have the authorized representative enroll in the REMS Program by completing the Healthcare Setting Enrollment Form and submitting it to the REMS Program.
  • Train all relevant staff that DSUVIA must not be dispensed for use outside of the certified healthcare setting.
  • Train all relevant staff involved in administration of DSUVIA to refer to the Directions for Use prior to administration.
  • Establish processes and procedures to verify that DSUVIA is not dispensed for use outside of the certified healthcare setting.
To maintain certification to dispense
  • Have a new authorized representative enroll in the REMS Program by completing the Healthcare Setting Enrollment Form if the authorized representative changes.
At all times
  • Not dispense DSUVIA for use outside the certified healthcare setting.
  • Not distribute, transfer, loan or sell DSUVIA.
  • Maintain records of staff training.
  • Maintain records of all processes and procedures including compliance with those processes and procedures.
  • Comply with audits by AcelRx Pharmaceuticals, Inc. or a third party acting on behalf of AcelRx Pharmaceuticals, Inc. to ensure that all processes and procedures are in place and are being followed.

Wholesalers-distributors that distribute Dsuvia must:

To be able to distribute
  • Establish processes and procedures to ensure that DSUVIA is distributed only to certified healthcare settings.
  • Train all relevant staff involved in distributing DSUVIA on the processes and procedures to verify the healthcare settings are certified.
At all times
  • Distribute only to certified healthcare settings.
  • Maintain and submit records of all shipments of DSUVIA to AcelRx Pharmaceuticals, Inc.
  • Comply with audits carried out by AcelRx Pharmaceuticals, Inc. or a third party acting on behalf of AcelRx Pharmaceuticals, Inc. to ensure that all processes and procedures are in place and are being followed.

What materials are included in the REMS?

The REMS includes a REMS Document. In addition, the REMS includes the following materials intended for patients and healthcare providers.

Material Name Material Name Link
Healthcare Setting Enrollment Form (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/rems/Dsuvia_2018_11_02_Healthcare Setting_Enrollment_Form.pdf
REMS Document (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/rems/Dsuvia_2018_11_02_REMS_Document.pdf
REMS Full (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/rems/Dsuvia_2018_11_02_REMS_Full.pdf
REMS Website Screenshots (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/rems/Dsuvia_2018_11_02_REMS_Website_Screenshots.pdf

What updates have been made to the REMS?

Date Summary of change
11/02/2018 Approval of REMS.

Disclaimer: This webpage provides general information about REMS programs to various REMS participants (e.g., patients, pharmacies, and healthcare providers). The summary information provided herein is not comprehensive and may not include all of the information relevant to REMS participants. This webpage does not constitute a replacement, modification, or revision of the approved REMS document, including any appended REMS materials. Refer to the approved REMS document for complete information on the REMS requirements for each approved application.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English